Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice

Liver International

Volumn 30, Issue 7, 2010, Pages 958-968

  Liu, Qu ^a   Shen, Wei Feng ^a   Sun, Han Yong ^a   Fan, Dan Feng ^a   Nakao, Atsunori ^b   Cai, Jian Mei ^a   Yan, Ge ^c   Zhou, Wei Ping ^a   Shen, Rong Xi ^a   Yang, Jia Mei ^a   Sun, Xue Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti oxidant; Hydrogen rich saline; Inflammation; Liver injury; Obstructive jaundice; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; HYDROGEN RICH SALINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER PROTECTIVE AGENT; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ENDOTOXIN; HBP1 PROTEIN, RAT; HIGH MOBILITY GROUP B1 PROTEIN; HYDROGEN; PEROXIDASE; SODIUM CHLORIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; LIVER INJURY; LOW DRUG DOSE; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; OXIDATIVE STRESS; RAT; WESTERN BLOTTING; ANIMAL; BLOOD; CELL PROTECTION; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; JAUNDICE, OBSTRUCTIVE; LIVER; LIVER DISEASES; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CATALASE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENDOTOXINS; HMGB1 PROTEIN; HYDROGEN; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1BETA; INTERLEUKIN-6; JAUNDICE, OBSTRUCTIVE; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956382547     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02254.x     Document Type: Article

References (51)

1. Tsuyuguchi T, Takada T, Miyazaki M. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg 2008, 15:69-73.
2. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 1988, 75:216-9.
3. Liu TZ, Lee KT, Chern CL. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor κB. Ann Clin Lab Sci 2001, 31:383-90.
4. Assimakopoulos SF, Vagianos CE, Zervoudakis G. Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. Regul Pept 2004, 120:185-93.
5. Vendemiale G, Grattagliano I, Lupo L. Hepatic oxidative alterations in patients with extra-hepatic cholestasis: effect of surgical drainage. J Hepatol 2002, 37:601-5.
6. Richter L, Hesselbarth N, Eitner K. Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction. J Hepatol 1996, 25:725-32.
7. Takaoka M, Kubota Y, Tsuji K. Human neutrophil functions in obstructive jaundice. Hepatogastroenterology 2001, 48:71-5.
8. Lechner AJ, Velasquez A, Knudsen KR. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998, 157:1550-8.
9. Ohsawa I, Ishikawa M, Takahashi K. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007, 13:688-94.
10. Fukuda K, Asoh S, Ishikawa M. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 2007, 361:670-4.
11. Hayashida K, Sano M, Ohsawa I. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008, 373:30-5.
12. Cai J, Kang Z, Liu K. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res 2009, 1256:129-37.
13. Sun Q, Kang Z, Cai J. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats. Exp Biol Med 2009, 1256:129-37.
14. Zheng X, Mao Y, Cai J. Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats. Free Radic Res 2009, 7:1-7.
15. Buchholz BM, Kaczorowski DJ, Sugimoto R. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant 2008, 8:2015-24.
16. Kajiya M, Sato K, Silva MJ. Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis. Biochem Biophys Res Commun 2009, 386:316-21.
17. Kajiya M, Silva MJ, Sato K. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate. Biochem Biophys Res Commun 2009, 386:11-5.
18. Alvaro D, Onori P, Metalli VD. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 2002, 36:297-304.
19. Thorne PS. Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation. Toxicology 2000, 152:13-23.
20. Tsai L, Lee K, Tsai S. The role of lipid peroxidation and antioxidants in animals with obstructive jaundice. J Biomed Lab Sci 1995, 7:1-8.
21. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 2006, 1762:256-65.
22. Gujral J, Farhood A, Bajt ML. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct ligated mice. Hepatology 2003, 38:355-63.
23. Gujral JS, Liu J, Farhood A. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 2004, 286:499-507.
24. Chosay JG, Essani NA, Dunn CJ. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997, 272:1195-200.
25. Lawson JA, Fisher MA, Simmons CA. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 1998, 28:761-7.
26. Van Bossuyt H, Desmaretz C, Gaeta GB. The role of bile acids in the development of endotoxemia during obstructive jaundice in rat. J Hepatol 1990, 10:274-9.
27. Assimakopoulos SF, Vagianos CE, Patsoukis N. Evidence for intestinal oxidative stress in obstructive jaundice induced gut barrier dysfunction in rats. Acta Physiol Scand 2004, 180:177-85.
28. Bemelmans MH, Gouma DJ, Greve JW. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstructive in mice. Hepatology 1992, 15:1132-6.
29. Hennet B, Richter C, Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J 1993, 289:587-92.
30. Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72:1493-505.
31. Moe KT, Aulia S, Jiang F. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 2006, 10:231-9.
32. Janssen YM, Van Houten B, Borm PJ. Cell and tissue responses to oxidative damage. Lab Invest 1993, 69:261-74.
33. Bonaldi T, Talamo F, Scaffidi P. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22:5551-60.
34. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-5.
35. Fiuza C, Bustin M, Talwar S. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-60.
36. Andersson U, Wang H, Palmblad K. HMGB-1 stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-70.
37. Wang H, Bloom O, Zhang M. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-51.
38. Yang H, Ochani M, Li JH. Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci 2004, 101:296-301.
39. Tsung A, Sahai R, Tanaka H. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201:1135-43.
40. Zhai Y, Shen XD, O'Connell R. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004, 173:7115-9.
41. Barsness KA, Arcaroli J, Harken AH. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 2004, 287:592-9.
42. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-5.
43. Qin S, Wang H, Li R. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006, 203:1637-42.
44. Abraham E, Arcaroli J, Carmody A. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-4.
45. Wang H, Vishnubbakat JM, Bloom O. Proinflammatory cytokines (tumor necrosis factor and interleukin 1 stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-92.
46. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-12.
47. Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation 2007, 116:1413-23.
48. Bha NR, Zhang P, Lee JC. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 1998, 18:1633-41.
49. Mi Jeong S, Davaatseren M, Kim W. Vitisin A suppresses LPS- induced NO production by inhibiting ERK, p38, and NF-κB activation in RAW 264.7 cells. Int Immunopharmacol 2009, 9:319-23.
50. Hsu JT, Kan WH, Hsieh CH. Role of extracellular signal-regulated protein kinase (ERK) in 17beta-estradiol- mediated attenuation of lung injury after trauma-hemorrhage. Surgery 2009, 145:226-34.
51. Schuh K, Pahl A. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury. Biochem. Pharmacol 2009, 77:1827-34.